S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

John Matthias Reimagines Vampire Lore Through a Biological Lens

A brutal, unexplained killing of three scientists in the Canadian Rockies forces FBI Special Agent Josh Cummings to confront a reality that defies forensic logic. In John Matthias’s new novel, Anatomy of a Vampire, the traditional supernatural mythos is replaced by a cold, calculated scientific framework of biological evolution.

John Matthias Reimagines Vampire Lore Through a Biological Lens
Photo: Bio & News

The investigation near Banff begins with a mystery that official channels dismiss as a grizzly bear attack, yet physical evidence tells a different story. Claw wounds suggest an assailant with an opposable grip, and a single, human-like footprint hints at a perpetrator far more dangerous than any wild animal. As Agent Cummings and detective Jean Ramsey dig deeper, they uncover a world where vampires exist not as ghosts or legends, but as flesh-and-blood organisms.

Parallel to the investigation, Ariel Lucard—a man who has remained ageless since a 1912 encounter in Romania—is drawn into a brewing war. Two ancient, hidden factions are emerging from the shadows, clashing over the future of humanity. Drawing on his own background in the biotech sector, Matthias crafts a narrative that blends procedural tension with speculative biology. The book is the second installment in the series, offering a gritty, grounded alternative to traditional fantasy tropes for readers who favor forensic detail over folklore.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!